Drug:
Reaction: HYPERSENSITIVITY
20260101 - 20261231
No. 701 - 800
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 701 | 26849230 |
US |
35 | 2 |
Weight increased, Dyspepsia, Heart rate increased, Anxiety, Arthralgia, Off label use, Pain in extremity, Depression, Hypersensitivity, Osteoporosis, Systemic lupus erythematosus, Frustration tolerance decreased, Illness, Asthenia, |
||||
RITUXIMAB, OBINUTUZUMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 702 | 26849894 |
|||
Application site laceration, Skin erosion, Hypersensitivity, Accidental exposure to product, |
||||
LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, |
||||
| 703 | 26850112 |
US |
69 | 2 |
Sinusitis, Cough, Sneezing, Hypersensitivity, Asthma, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 704 | 26850313 |
US |
61 | 2 |
Intentional product misuse, Pain in extremity, Musculoskeletal stiffness, Glaucoma, Therapeutic response unexpected, Abdominal distension, Constipation, Osteoporosis, Nasopharyngitis, Influenza, Hypersensitivity, Vertigo, Pain, Muscle spasms, Muscle strain, |
||||
TOFACITINIB, TOFACITINIB, ALENDRONATE SODIUM, ALENDRONATE SODIUM TABLET, NAPROXEN SODIUM, NAPROXEN SODIUM TABLET, MELOXICAM, |
||||
| 705 | 26850438 |
US |
69 | 1 |
Dermatitis atopic, Therapeutic response decreased, Pruritus, Dermatitis, Sinusitis, Adenoiditis, Rhinorrhoea, Oropharyngeal pain, Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 706 | 26850443 |
US |
82 | 1 |
Arthralgia, Gait disturbance, Balance disorder, Abdominal pain upper, Asthenia, Feeling abnormal, Illness, Pneumonia, Myocarditis, Cerebrovascular accident, Atrial thrombosis, Pain, Rash maculo-papular, Ejection fraction decreased, Rash, Hypersensitivity, Eosinophil count increased, Inflammation, |
||||
DUPILUMAB, MONTELUKAST SODIUM, |
||||
| 707 | 26850475 |
US |
2 | |
Hypersensitivity, Swelling face, Purulent discharge, |
||||
| 708 | 26850755 |
RU |
79 | 2 |
Arrhythmia, Hypersensitivity, Pruritus, |
||||
INSULIN GLARGINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 709 | 26850949 |
US |
1 | |
Anaphylactic reaction, Hypersensitivity, |
||||
OMALIZUMAB, |
||||
| 710 | 26850992 |
US |
50 | 2 |
Syncope, Wound, Musculoskeletal stiffness, Fatigue, Malaise, Hypersensitivity, |
||||
GALCANEZUMAB-GNLM, UBROGEPANT, ATOGEPANT, ONABOTULINUMTOXINA, |
||||
| 711 | 26851242 |
BR |
2 | |
Hypersensitivity, Injection site discomfort, |
||||
TIRZEPATIDE, |
||||
| 712 | 26851261 |
BR |
40 | 2 |
Hypersensitivity, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 713 | 26851379 |
US |
82 | 2 |
Cough, Sneezing, Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 714 | 26851741 |
US |
2 | |
Hypersensitivity, |
||||
MINOXIDIL, MINOXIDIL FOAM 5% (WOMENS), |
||||
| 715 | 26851827 |
52 | ||
Vertigo, Dizziness, Nausea, Hypersensitivity, Restless legs syndrome, |
||||
OLEZARSEN SODIUM, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ALBUTEROL SULFATE, AMLODIPINE, APIXABAN, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CYANOCOBALAMIN, DOXEPIN, DOXEPIN HYDROCHLORIDE, EZETIMIBE, FLUTICASONE PROPIONATE, FUROSEMIDE, GABAPENTIN, ICOSAPENT ETHYL, ICOSAPENT ETHYL CAPSULES, INSULIN ASPART, INSULIN DEGLUDEC, EMPAGLIFLOZIN, LATANOPROST, LIDOCAINE AND PRILOCAINE, LISINOPRIL, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, MONTELUKAST, NALOXONE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, OXCARBAZEPINE, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, DESVENLAFAXINE SUCCINATE, EVOLOCUMAB, ROPINIROLE, ROSUVASTATIN, SODIUM BICARBONATE, SODIUM BICARBONATE, INJECTION, SODIUM BICARBONATE INJECTION,, |
||||
| 716 | 26846158 |
US |
71 | |
Hypersensitivity, Chronic obstructive pulmonary disease, |
||||
DUPILUMAB, |
||||
| 717 | 26846196 |
US |
92 | 2 |
Hypopnoea, Upper respiratory tract congestion, Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 718 | 26846274 |
US |
54 | 2 |
Hypersensitivity, |
||||
TIRZEPATIDE, |
||||
| 719 | 26846578 |
US |
78 | 2 |
Hypersensitivity, Cough, |
||||
EVOLOCUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, SACUBITRIL AND VALSARTAN, |
||||
| 720 | 26845085 |
CA |
44 | 2 |
Maternal exposure during pregnancy, Maternal exposure during pregnancy, Contraindicated product administered, Drug intolerance, Exposure during pregnancy, Gastrointestinal disorder, Glossodynia, Helicobacter infection, Hypersensitivity, Ill-defined disorder, Infusion related reaction, Irritable bowel syndrome, Live birth, Lower respiratory tract infection, Maternal exposure timing unspecified, Pericarditis, Peripheral swelling, Pregnancy, Prescribed overdose, Product use issue, Pruritus, Pyrexia, Rheumatoid arthritis, Sinusitis, Stomatitis, Synovitis, Systemic lupus erythematosus, Therapeutic product effect decreased, Therapy non-responder, Treatment failure, Underdose, Weight increased, Wound, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LEFLUNOMIDE, AZATHIOPRINE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, DESOXIMETASONE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, GOLD, GOLD, GOLIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, ABATACEPT, ABATACEPT, ABATACEPT, SULFASALAZINE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, LEFLUNOMIDE, GOLIMUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TRAMADOL HYDROCHLORIDE, ERGOCALCIFEROL, DICLOFENAC SODIUM, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, CAFFEINE CITRATE, CALCIUM GLUCONATE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LISINOPRIL, NAPROXEN, NAPROXEN SODIUM, PANTOPRAZOLE, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, TOFACITINIB CITRATE, |
||||
| 721 | 26845134 |
US |
53 | 2 |
Hypersensitivity, Eye swelling, Pustule, Ocular hyperaemia, Eye discharge, |
||||
DUPILUMAB, |
||||
| 722 | 26845145 |
US |
61 | 1 |
Hypersensitivity, Off label use, |
||||
DUPILUMAB, |
||||
| 723 | 26845198 |
US |
2 | |
Pyrexia, Rash, Muscle contractions involuntary, Tremor, Hypersensitivity, |
||||
ZILUCOPLAN, |
||||
| 724 | 26845295 |
EU |
58 | 1 |
Iridocyclitis, Hospitalisation, Tuberculosis, Pyrexia, Seizure, Speech disorder, Back pain, Arthralgia, General physical health deterioration, C-reactive protein increased, Pyrexia, Hypersensitivity, Cough, Mycobacterium tuberculosis complex test positive, C-reactive protein increased, Hepatic enzyme increased, Granuloma, Splenomegaly, Drug ineffective, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, INFLIXIMAB, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, |
||||
| 725 | 26845417 |
US |
28 | 1 |
Hypersensitivity, Dyspnoea, Ocular hyperaemia, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 726 | 26845443 |
PR |
46 | 2 |
Hypersensitivity, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 727 | 26845490 |
US |
50 | 2 |
Hepatic enzyme increased, Hypersensitivity, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 728 | 26849932 |
50 | 1 | |
Hypersensitivity, Infusion related reaction, |
||||
EPTINEZUMAB-JJMR, |
||||
| 729 | 26856205 |
42 | ||
Hypersensitivity, Dyspnoea, Heart rate increased, |
||||
NITROFURANTOIN, NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS, NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), |
||||
| 730 | 26839593 |
CA |
40 | 2 |
Product use in unapproved indication, Rash, Therapeutic product effect decreased, Taste disorder, Sleep disorder, Treatment failure, Wheezing, Wound, Glossodynia, Fall, Weight increased, Fatigue, Gait inability, Insomnia, Ill-defined disorder, Dry mouth, Fibromyalgia, Condition aggravated, Gastrooesophageal reflux disease, Blood cholesterol increased, Contraindicated product administered, Arthropathy, Hypersensitivity, Exposure during pregnancy, Malaise, Hypertension, Swelling, Mobility decreased, |
||||
SECUKINUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM, CANDESARTAN, LEFLUNOMIDE, MAGNESIUM, RITUXIMAB, ERENUMAB-AOOE, OXYCODONE HYDROCHLORIDE, OXYCODONE, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ERENUMAB-AOOE, DICLOFENAC, DICLOFENAC SODIUM, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, DICLOFENAC SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC, DICLOFENAC SODIUM, ACETAMINOPHEN AND CODEINE, CELECOXIB, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, SULFASALAZINE, |
||||
| 731 | 26839990 |
US |
2 | |
Dyspnoea, Hypersensitivity, |
||||
MINOXIDIL, |
||||
| 732 | 26839998 |
US |
49 | 2 |
Paranasal sinus inflammation, Nasopharyngitis, Paranasal sinus discomfort, Product container issue, Hypersensitivity, Medication error, |
||||
ALECTINIB HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 733 | 26840041 |
US |
2 | |
Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 734 | 26840265 |
US |
1 | |
Depression, Erythema, Rash, Hypersensitivity, Extra dose administered, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, LOVASTATIN, VALPROIC ACID, ALPRAZOLAM, |
||||
| 735 | 26840293 |
US |
38 | 2 |
Hyperhidrosis, Hypersensitivity, Asthma, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, AZELASTINE HYDROCHLORIDE, AZELASTINE, IVABRADINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, EPINEPHRINE, ADRENALINUM, FLUVOXAMINE MALEATE, LEVALBUTEROL HYDROCHLORIDE, LIDOCAINE 4%, LIDOCAINE, LIDOCAINE 5%, LIDOCAINE, 0.5%, LIDOCAINE HCL 3%, LIDOCAINE 0.5%, MAGNESIUM, MIDODRINE HYDROCHLORIDE, MONTELUKAST SODIUM, MONTELUKAST, NALTREXONE HYDROCHLORIDE, BEMPEDOIC ACID, FAMOTIDINE, BECLOMETHASONE DIPROPIONATE, ATOGEPANT, THYROID, IODIUM,BADIAGA,FUCUS VESICULOSUS,CALCAREAARSENICUM IODATUM, THYROIDINUM,CARBONICA,PULSATILLA,BARYTA CARBONICA,, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, UBROGEPANT, ERGOCALCIFEROL, LEVALBUTEROL TARTRATE, CETIRIZINE HYDROCHLORIDE, |
||||
| 736 | 26840309 |
US |
2 | |
Anaphylactic reaction, Hypersensitivity, Paraesthesia oral, |
||||
EVOLOCUMAB, |
||||
| 737 | 26840443 |
US |
2 | |
Hypersensitivity, Feeling abnormal, |
||||
VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, |
||||
| 738 | 26840493 |
CA |
40 | 2 |
Nausea, Fall, Hand deformity, Dyspepsia, Liver function test increased, Dyspnoea, Back injury, Swelling, Hypersensitivity, Glossodynia, Abdominal distension, Vomiting, Hypertension, Onychomadesis, Folliculitis, Osteoarthritis, Drug hypersensitivity, Gastrooesophageal reflux disease, Product label confusion, Confusional state, Mobility decreased, |
||||
SECUKINUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, INFLIXIMAB, RAMIPRIL, RAMIPRIL, RAMIPRIL, RAMIPRIL, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, OXYCODONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, MAGNESIUM HYDROXIDE, LEFLUNOMIDE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ETANERCEPT, CANDESARTAN, ACETAMINOPHEN AND CODEINE, ACETAMINOPHEN AND CODEINE, CELECOXIB, CELECOXIB, LAMOTRIGINE, SARILUMAB, SARILUMAB, ADALIMUMAB, ADALIMUMAB, |
||||
| 739 | 26840571 |
US |
||
Hypersensitivity, Illness, |
||||
ACORAMIDIS HYDROCHLORIDE, |
||||
| 740 | 26840583 |
US |
2 | |
Hypersensitivity, Rash, Throat irritation, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
| 741 | 26840614 |
US |
2 | |
Respiratory tract infection, Hypersensitivity, |
||||
DUPILUMAB, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, BUPROPION, CETIRIZINE HCL, CETIRIZINE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, |
||||
| 742 | 26840705 |
70 | 2 | |
Hypersensitivity, Urticaria, Macule, Pruritus, Abdominal pain upper, Nausea, Product use in unapproved indication, Incorrect product administration duration, |
||||
OMEPRAZOLE MAGNESIUM, |
||||
| 743 | 26840711 |
US |
||
Urticaria, Oropharyngeal pain, Fatigue, Hypersensitivity, |
||||
DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE, |
||||
| 744 | 26841353 |
US |
2 | |
Hypersensitivity, |
||||
TIRZEPATIDE, |
||||
| 745 | 26841389 |
US |
70 | 2 |
Hypersensitivity, Rash, |
||||
SARILUMAB, |
||||
| 746 | 26841633 |
CA |
34 | |
Harvey-Bradshaw index increased, Arthralgia, Chest discomfort, Symptom recurrence, Drug level abnormal, Swollen tongue, Erythema, Hypersensitivity, Dyspnoea, Rash, Infusion site rash, Pruritus, Rash, Off label use, Therapeutic response decreased, Inappropriate schedule of product administration, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 747 | 26841794 |
US |
57 | 2 |
Lung neoplasm malignant, Off label use, Mental disorder, Dry skin, Rhinorrhoea, Dehydration, Diarrhoea, Epistaxis, Visual impairment, Arthralgia, Bone pain, Sinus congestion, Hypersensitivity, |
||||
SOTORASIB, SOTORASIB, MINOCYCLINE, |
||||
| 748 | 26841997 |
US |
25 | 2 |
Anaphylactic reaction, Hypersensitivity, Migraine, Infusion related reaction, Drug ineffective, |
||||
TOCILIZUMAB, TOCILIZUMAB, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 749 | 26842090 |
US |
1 | |
Bed bug infestation, Hypersensitivity, Drug ineffective, |
||||
DUPILUMAB, ALBUTEROL SULFATE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, GABAPENTIN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, INSULIN LISPRO, EMPAGLIFLOZIN, LISINOPRIL, MIRTAZAPINE, ROSUVASTATIN CALCIUM, TAMSULOSIN HYDROCHLORIDE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, INSULIN DEGLUDEC, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 750 | 26842156 |
US |
45 | 2 |
Lip swelling, Hypersensitivity, |
||||
UBROGEPANT, |
||||
| 751 | 26842158 |
US |
36 | 1 |
Hypersensitivity, Nausea, Throat irritation, Hyperhidrosis, Abdominal pain, Ocular hyperaemia, Dizziness, Feeling hot, Heart rate increased, |
||||
SULFUR HEXAFLUORIDE, SULFUR HEXAFLUORIDE, SULFUR HEXAFLUORIDE, |
||||
| 752 | 26842398 |
EU |
64 | 2 |
Hypersensitivity, Laryngeal oedema, Rash, |
||||
LETROZOLE, LETROZOLE TABLETS, RIBOCICLIB, |
||||
| 753 | 26842463 |
US |
11 | 2 |
Hypersensitivity, Swelling face, Dyspnoea, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 754 | 26842622 |
US |
29 | |
Hypersensitivity, |
||||
EMTRICITABINE AND TENOFOVIR ALAFENAMIDE, |
||||
| 755 | 26842788 |
US |
72 | 2 |
Condition aggravated, Hypersensitivity, Rash, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, TIRZEPATIDE, |
||||
| 756 | 26842819 |
US |
2 | |
Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 757 | 26842831 |
US |
52 | 2 |
Asthma, Lip pruritus, Throat irritation, Fatigue, Injection site pain, Hypersensitivity, |
||||
DUPILUMAB, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, FLUTICASONE PROPIONATE, HYDROCHLOROTHIAZIDE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 758 | 26842985 |
US |
1 | |
Hypersensitivity, Application site pruritus, |
||||
BUPRENORPHINE, |
||||
| 759 | 26843053 |
US |
||
Arthralgia, Fatigue, Hypersensitivity, Liver function test abnormal, Hypokinesia, Pain, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, |
||||
| 760 | 26843093 |
US |
1 | |
Blister, Hypersensitivity, |
||||
BUPRENORPHINE, |
||||
| 761 | 26843119 |
US |
2 | |
Pyrexia, Hypersensitivity, Application site vesicles, Pruritus, |
||||
BUPRENORPHINE, |
||||
| 762 | 26843224 |
CN |
19 | 1 |
Hypersensitivity, Blood pressure decreased, |
||||
GADOTERATE MEGLUMINE, |
||||
| 763 | 26843764 |
CA |
59 | 2 |
Oedema peripheral, Bronchitis, Nasopharyngitis, Fibromyalgia, Malaise, Fatigue, Rheumatoid arthritis, Hypersensitivity, Musculoskeletal stiffness, Duodenal ulcer perforation, Type 2 diabetes mellitus, Adverse event, Therapeutic product effect decreased, Rheumatic fever, Lupus vulgaris, Joint swelling, Hypertension, Alopecia, Decreased appetite, Pemphigus, Therapeutic product effect incomplete, Helicobacter infection, Discomfort, Anti-cyclic citrullinated peptide antibody positive, Retinitis, Hypercholesterolaemia, Abdominal discomfort, Blood cholesterol increased, Hypoaesthesia, Contraindicated product administered, |
||||
SECUKINUMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, SECUKINUMAB, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, OXYCODONE, PHENYLEPHRINE HYDROCHLORIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RAMIPRIL, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, TOFACITINIB CITRATE, DESOXIMETASONE, USTEKINUMAB, VITAMIN C, ERGOCALCIFEROL, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, USTEKINUMAB, ADALIMUMAB, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, LANSOPRAZOLE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TELMISARTAN, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOFACITINIB CITRATE, TOFACITINIB CITRATE, GOLIMUMAB, ADALIMUMAB-ADAZ, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, LANSOPRAZOLE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, BUPROPION, ACETAMINOPHEN AND CODEINE, LISINOPRIL, CAFFEINE CITRATE, HYDROMORPHONE HYDROCHLORIDE, QUETIAPINE FUMARATE, QUETIAPINE, LORAZEPAM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, BUPROPION HYDROCHLORIDE, SULFASALAZINE, |
||||
| 764 | 26844260 |
US |
||
Swelling face, Vision blurred, Palpitations, Arthralgia, Back pain, Tooth infection, Alopecia, Hypersensitivity, Injection site swelling, No adverse event, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, |
||||
| 765 | 26844373 |
CN |
68 | 2 |
Dyspnoea, Oxygen saturation decreased, Blood pressure increased, Mental disorder, Hypersensitivity, |
||||
ALTEPLASE, ALTEPLASE, IOHEXOL, |
||||
| 766 | 26844440 |
US |
||
Hypersensitivity, Alopecia, |
||||
TIRZEPATIDE, |
||||
| 767 | 26844861 |
US |
||
Hypersensitivity, |
||||
PROGESTERONE, |
||||
| 768 | 26849032 |
|||
Hypersensitivity, |
||||
NINTEDANIB, |
||||
| 769 | 26849098 |
64 | 2 | |
Increased appetite, Pruritus, Hypersensitivity, Injection site pruritus, Injection site rash, Food craving, |
||||
TIRZEPATIDE, |
||||
| 770 | 26834943 |
EU |
4 | 2 |
Hypersensitivity, Skin test negative, |
||||
| 771 | 26835027 |
US |
2 | |
Product dose omission issue, Urticaria, Hypersensitivity, Accidental exposure to product, Product temperature excursion issue, Wrong technique in product usage process, Device issue, |
||||
OMALIZUMAB, ETANERCEPT, |
||||
| 772 | 26835042 |
US |
2 | |
Wrong technique in product usage process, Product communication issue, Hypersensitivity, |
||||
EVOLOCUMAB, CETIRIZINE HYDROCHLORIDE, |
||||
| 773 | 26835233 |
US |
33 | 2 |
Erythema, Hand dermatitis, Pruritus, Eye pruritus, Eye discharge, Burning sensation, Skin exfoliation, Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 774 | 26835259 |
US |
2 | |
Hypersensitivity, Wrong technique in product usage process, Incorrect dose administered, Discomfort, Fall, |
||||
| 775 | 26835321 |
CA |
43 | 2 |
Abdominal discomfort, Abdominal pain, Abdominal pain upper, Adjustment disorder with depressed mood, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Autoimmune disorder, Back disorder, Blepharospasm, Blister, Blood cholesterol increased, Bone erosion, Breast cancer stage II, Breast cancer stage III, Bursitis, C-reactive protein abnormal, C-reactive protein increased, Chest pain, Condition aggravated, Confusional state, Contusion, Decreased appetite, Deep vein thrombosis postoperative, Delirium, Depression, Diarrhoea, Disability, Discomfort, Dislocation of vertebra, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Epilepsy, Facet joint syndrome, Fatigue, Feeling hot, Fibromyalgia, Fluid retention, Folliculitis, Frequent bowel movements, Gait disturbance, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, General symptom, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hip arthroplasty, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Infection, Inflammation, Infusion related reaction, Injury, Intentional product misuse, Intentional product use issue, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Knee arthroplasty, Laboratory test abnormal, Lip dry, Liver injury, Lower respiratory tract infection, Lung disorder, Malaise, Maternal exposure during pregnancy, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Musculoskeletal pain, Musculoskeletal stiffness, Myositis, Nail disorder, Nasopharyngitis, Nausea, Night sweats, Obesity, Oedema, Oedema peripheral, Off label use, Osteoarthritis, Overlap syndrome, Pain, Pain in extremity, Pancreatitis, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Porphyria acute, Product quality issue, Product use in unapproved indication, Pruritus, Psoriatic arthropathy, Pulmonary fibrosis, Pustular psoriasis, Pyrexia, Rash, Rash vesicular, Rectal haemorrhage, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Road traffic accident, Sciatica, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, mixed type, Stomatitis, Subcutaneous drug absorption impaired, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Taste disorder, Therapy non-responder, Type 2 diabetes mellitus, Underdose, Urticaria, Vomiting, Weight decreased, Weight increased, Wheezing, White blood cell count increased, Wound, Wound infection, X-ray abnormal, |
||||
TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, |
||||
| 776 | 26835465 |
US |
45 | 2 |
Hypersensitivity, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 777 | 26835560 |
US |
68 | 2 |
Hypersensitivity, Chills, Productive cough, Nocturnal dyspnoea, |
||||
LENALIDOMIDE, |
||||
| 778 | 26835566 |
US |
61 | |
Hypersensitivity, Heart rate increased, |
||||
IXEKIZUMAB, IXEKIZUMAB, |
||||
| 779 | 26835952 |
80 | 1 | |
Generalised bullous fixed drug eruption, Hypersensitivity, Rash, Therapy non-responder, |
||||
CLOPIDOGREL, CLOPIDOGREL BISULFATE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, CEFTRIAXONE, CEFTRIAXONE SODIUM, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CEFEPIME HYDROCHLORIDE, CEFEPIME, NITROGLYCERIN, |
||||
| 780 | 26836335 |
US |
2 | |
Illness, Hypersensitivity, |
||||
TIRZEPATIDE, |
||||
| 781 | 26836350 |
US |
||
Hypersensitivity, |
||||
INFLIXIMAB, |
||||
| 782 | 26836417 |
US |
53 | |
Hypersensitivity, Sinus disorder, Nasopharyngitis, Dyspnoea, Nasal congestion, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 783 | 26836627 |
CA |
43 | 2 |
Arthralgia, Deep vein thrombosis postoperative, Hypersensitivity, Maternal exposure during pregnancy, Joint swelling, Leukopenia, Psoriatic arthropathy, Hand deformity, Hypertransaminasaemia, Contraindicated product administered, Urticaria, Product use in unapproved indication, Therapeutic response decreased, Therapy non-responder, Decreased appetite, Adverse drug reaction, Polyarthritis, Prescribed overdose, C-reactive protein abnormal, Psoriasis, Loss of consciousness, Joint destruction, |
||||
ERENUMAB-AOOE, ERENUMAB-AOOE, USTEKINUMAB, USTEKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CALCIUM CHLORIDE INJECTION, CALCIUM CHLORIDE, CALCIUM GLUCONATE, CALCIUM GLUCONATE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, SARILUMAB, SARILUMAB, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, CALCIUM CARBONATE, HYDROCORTISONE ACETATE, |
||||
| 784 | 26836642 |
CA |
77 | 1 |
Drug reaction with eosinophilia and systemic symptoms, Eosinophil count increased, Hepatic enzyme increased, Hypersensitivity, Pneumonia, Pulmonary toxicity, Rash, |
||||
MEROPENEM, PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM, PIPERACILLIN AND TAZOBACTAM, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, MOXIFLOXACIN, MOXIFLOXACIN HYDROCHLORIDE, |
||||
| 785 | 26836724 |
US |
2 | |
Ulcer, Hypersensitivity, Chest pain, Nasal septum deviation, Dyspnoea, Pain in jaw, Abdominal pain upper, Inappropriate schedule of product administration, Pruritus, Rash, Asthma, Cardiac aneurysm, Syncope, |
||||
OMALIZUMAB, |
||||
| 786 | 26837234 |
US |
69 | 2 |
Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 787 | 26837412 |
US |
2 | |
Vulvovaginal erythema, Hypersensitivity, Vulvovaginal pruritus, |
||||
MICONAZOLE NITRATE, JOCK ITCH SPRAY, ANTIFUNGAL LIQUID CONTINUOUS SPRAY, ATHLETES FOOT LIQUID, ANTI-FUNGAL POWDER MICONAZOLE NITRATE TALC FREE, ANTIFUNGAL MICONAZOLE POWDER SPRAY, JOCK ITCH SPRAY TALC FREE, ANTIFUNGAL MICONAZOLE LIQUID CONTINUOUS SPRAY, MICONAZOLE NITRATE ANTIFUNGAL POWDER SPRAY, ATHLETES FOOT POWDER SPRAY TALC FREE, ATHLETES FOOT SPRAY, ANTIFUNGAL POWDER SPRAY, ANTIFUNGAL, ANTI-FUNGAL MICONAZOLE ATHLETES FOOT SPRAY TALC FREE, |
||||
| 788 | 26837667 |
EU |
2 | |
Influenza like illness, Hypersensitivity, |
||||
OFATUMUMAB, |
||||
| 789 | 26838001 |
2 | ||
Hypersensitivity, Dizziness, Hypotonia, Rash, Tachypnoea, Oxygen saturation decreased, |
||||
GADOBUTROL, |
||||
| 790 | 26838102 |
|||
Hypersensitivity, |
||||
OCRELIZUMAB, |
||||
| 791 | 26838253 |
US |
2 | |
Hypersensitivity, Eye pruritus, |
||||
TEPROTUMUMAB, |
||||
| 792 | 26838338 |
US |
17 | 2 |
Hiccups, Hypersensitivity, Eczema, Throat tightness, |
||||
CEPHALEXIN, |
||||
| 793 | 26838523 |
CN |
4 | 2 |
Hypersensitivity, Rash erythematous, Condition aggravated, Scratch, Pruritus, |
||||
AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, |
||||
| 794 | 26838565 |
|||
Inappropriate schedule of product administration, Hypersensitivity, |
||||
FAMOTIDINE, |
||||
| 795 | 26838967 |
US |
16 | 1 |
Hypersensitivity, |
||||
DUPILUMAB, |
||||
| 796 | 26829755 |
US |
35 | 2 |
Hypersensitivity, Dermatitis atopic, |
||||
DUPILUMAB, |
||||
| 797 | 26829859 |
74 | 1 | |
Dizziness, Hypotension, Hypersensitivity, |
||||
CETUXIMAB, |
||||
| 798 | 26829910 |
US |
2 | |
Hypersensitivity, Pain, Posture abnormal, |
||||
LANREOTIDE ACETATE, ALPRAZOLAM, ATENOLOL, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, CITALOPRAM, CITALOPRAM HYDROBROMIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, PANTOPRAZOLE SODIUM, RAMIPRIL, SPIRONOLACTONE, LEVOTHYROXINE SODIUM, TEMAZEPAM, VITAMIN C, |
||||
| 799 | 26830209 |
EU |
50 | |
Gastrointestinal disorder, Hypersensitivity, Drug hypersensitivity, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, METHOTREXATE, METHOTREXATE SODIUM, BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 800 | 26830522 |
EU |
40 | 2 |
Burning sensation, Hypersensitivity, Rash maculo-papular, Oedema peripheral, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30